INDIANAPOLIS--(BUSINESS WIRE)--Prosolia, Inc., the exclusive manufacturer of DESI systems, introduces a new DESI 2D model compatible with Agilent TOF, Q-TOF and IM-Q-TOF LC/MS systems. With no sample prep required, DESI 2D enables molecular imaging without matrix by mass spectrometry. DESI 2D integrates real time, micro-scale solvent extraction in fast-moving droplets with electrospray ionization for direct sample analysis. The announcement came at the 65th conference of the American Society of Mass Spectrometry (ASMS).
DESI 2D incorporates Prosolia’s proprietary Desorption Electrospray Ionization technology and is currently used in preclinical and clinical research for determining the distribution of drugs, metabolites and biomarkers of disease, as well as, a variety of chemical analysis applications.
“DESI 2D is the leading ambient molecular imaging platform for mass spectrometry enabling pharmaceutical and medical research,” said Dr. Justin Wiseman, Chairman, President & CEO of Prosolia. “We are delighted to offer DESI 2D systems compatible with Agilent TOF, Q-TOF and Ion Mobility Q-TOF systems opening up new possibilities for current and future Agilent users.”
About Prosolia, Inc.
Prosolia is a pioneer of direct mass spectrometric solutions that speed up the sample to answer paradigm. Our portfolio of scientific tools includes innovative sample introduction, ionization and surface analysis systems, along with intuitive software, all of which are part of workflows that reduce analytical complexity and yield faster time to results. The unique capabilities of DESI 2D, flowprobe and the Velox 360 provide customers the benefits of reduced time-to-results and streamlined analytical workflows resulting in increased cost efficiencies.